跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/NCT00002117
NCT00002117已完成3 期

A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection

Hoffmann-La Roche24 个研究点 分布在 1 个国家目标入组 528 人开始时间: 2001年8月31日最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
528
试验地点
24
研究概览研究设计入排标准研究者研究点记录与标识符相似试验

研究概览

简要总结

To investigate the appropriate zalcitabine ( dideoxycytidine; ddC ) dose and zidovudine ( AZT ) schedule for use in combination therapy in patients with HIV infection.

详细描述

Patients are randomized to one of four treatment arms. ddC is administered at 1 of 2 doses every 8 hours. AZT is administered at 1 of 2 doses (every 4 hours while awake or every 8 hours).

研究设计

研究类型
Interventional
主要目的
Treatment

入排标准

年龄范围
18 Years 至 —（Adult, Older Adult）
性别
All
接受健康志愿者
否

入选标准

  • •Patients must have:
  • •HIV infection.
  • •CD4 count 100 - 500 cells/mm3.

排除标准

  • 未提供

研究者

申办方类型
Industry

研究点 (24)

Loading locations...

相似试验

已完成
1 期
A Study of Dideoxycytidine Plus Zidovudine in the Treatment of AIDS or Advanced AIDS Related Complex (ARC)HIV Infections
NCT00000978National Institute of Allergy and Infectious Diseases (NIAID)68
已完成
2 期
Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.HIV Infections
NCT00000678National Institute of Allergy and Infectious Diseases (NIAID)320
已完成
不适用
A Clinical Trial of Alternating and Intermittent Regimens of 2',3'-Dideoxycytidine and 3'-Azido-3'-Deoxythymidine in the Treatment of Patients With AIDS and Advanced ARCHIV Infections
NCT00000718National Institute of Allergy and Infectious Diseases (NIAID)112
已完成
2 期
(Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus Zidovudine (AZT) in Patients With AIDS or Advanced ARCHIV Infections
NCT00000679National Institute of Allergy and Infectious Diseases (NIAID)600
已完成
3 期
A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV TherapyHIV Infections
NCT00000651National Institute of Allergy and Infectious Diseases (NIAID)750